|
de Leon, J H; Vatsis, K P; Weber, W W (2000) Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1. Mol Pharmacol 58:288-99
|
|
Estrada, L; Kanelakis, K C; Levy, G N et al. (2000) Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1. Drug Metab Dispos 28:139-46
|
|
Estrada-Rodgers, L; Levy, G N; Weber, W W (1998) Characterization of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter. Gene Expr 7:13-24
|
|
Estrada-Rodgers, L; Levy, G N; Weber, W W (1998) Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells. Drug Metab Dispos 26:502-5
|
|
Levy, G N; Rodgers, L; Weber, W W (1996) Effects of heredity on response to drugs and environmental chemicals: construction of rodent models. Chem Res Toxicol 9:1215-24
|
|
De Leon, J H; Martell, K J; Vatsis, K P et al. (1995) Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9). Drug Metab Dispos 23:1354-61
|
|
Vatsis, K P; Weber, W W; Bell, D A et al. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17
|
|
Weber, W W (1995) Influence of heredity on human sensitivity to environmental chemicals. Environ Mol Mutagen 25 Suppl 26:102-14
|
|
Voice, R A; Manis, M; Weber, W W (1993) Inhibition of human red blood cell N-acetyltransferase. Drug Metab Dispos 21:181-3
|
|
Smolen, T N; Brewer, J A; Weber, W W (1993) Testosterone modulation of N-acetylation in mouse kidney. J Pharmacol Exp Ther 264:854-8
|
Showing the most recent 10 out of 19 publications
